Research conducted by surgeons from the Methodist DeBakey Heart & Vascular Center shows that using robotics reduces blood vessel trauma during minimally invasive procedures to repair diseased arteries. Research results were presented at the Society for Vascular Surgery’s 2010 Vascular Annual Meeting in Boston. Continue Reading
CAS Medical Systems, Inc. today announced that a new study published in The Journal of Thoracic and Cardiovascular Surgery supports the association between decreased perioperative cerebral oxygenation values and poor outcomes after aortic arch surgery. Continue Reading
The mammalian fucose mutarotase enzyme is known to be involved in incorporating the sugar fucose into protein. Female mice that lack the fucose mutarotase (FucM) gene refuse to let males mount them, and will attempt copulation with other female mice. Researchers writing in BioMed Central’s open access journal BMC Genetics created the FucM mouse mutants in order to investigate the role of this enzyme in vivo. Continue Reading
The scientists at the European Molecular Biology Laboratory in Heidelberg, Germany, who ‘fathered’ the Digital Embryo have now given it wings, creating the Fly Digital Embryo. In work published today in Nature Methods, they were able to capture fruit fly development on film, and were the first to clearly record how a zebrafish’s eyes and midbrain are formed. Continue Reading
Research and Markets has announced the addition of the “European Markets for Neurological Devices 2010 (15 Countries)” report to their offering. Continue Reading
With impending lawsuits from states, an uprising from the Tea Party sect and an outpouring of rhetoric from both major parties, the healthcare debate is far from over. Continue Reading
AGA Medical Holdings, Inc. today announced first patient enrollment in the feasibility phase of the prospective, multicenter, randomized AMPLATZER® Cardiac Plug clinical trial. Dr. William Nicholson, an interventional cardiologist and structural heart specialist at York Hospital in Pennsylvania, enrolled the first patient. Continue Reading
Evotec AG today announced that a compound in its strategic alliance with Boehringer Ingelheim has advanced into clinical trials. With the initiation of the Phase I clinical studies for this compound, Evotec will receive a milestone payment of EUR 2.0 million. Continue Reading
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will initiate a Phase IIb clinical trial for ZoraxelTM in the treatment of erectile dysfunction (ED). Continue Reading
The news that Vice President Joe Biden’s 41-year-old son has suffered a stroke is highlighting the problem of strokes in young people. Continue Reading
